Objective
To evaluate the efficacy of the NV900 on reducing methicillin-resistant Staphylococcus aureus (MRSA).
Methodology
The challenge bacteria were aerosolized using a six-jet collision nebulizer under high pressure air and introduced into the chamber with the NV900.
Summary of Results
The NV800/NV900 reduced 99.99% of methicillin-resistant Staphylococcus aureus (MRSA) bacteria over the course of four hours.